Records containing: Overactive Bladder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-05-20Behavioral Treatment of Overactive Bladder in Men
-
CLINICAL_TRIALS study record update · 2014-04-21Botulin-A Toxin/Dimethyl Sulfoxide Bladder Instillations for Treatment of Voiding Dysfunction Secondary to Detrusor Hyperreflexia and Detrusor Instability in Women
-
CLINICAL_TRIALS study record update · 2014-04-07A Study to Evaluate the Overall Effect of Solifenacin 5mg and 10mg on Bladder Wall Thickness and Urinary Nerve Growth Factor in Female Subjects With Overactive Bladder and a Diagnosis of Detrusor Overactivity - A Double-blind, Randomised, Placebo-controlled, Parallel Group, Multi-centre Study.
-
CLINICAL_TRIALS study record update · 2014-03-20Multi-site, Randomized, Opened and Controlled Comparison Study on the Effectiveness and Safety of Solifenacin Succinate Tablets and Solifenacin Succinate Tablets + Estrogen for Overactive Bladder in the Post-menopausal Women
-
CLINICAL_TRIALS study record update · 2014-03-12A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-02-05Prospective Randomized Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
-
CLINICAL_TRIALS study record update · 2014-01-24ClinicalTrials.gov study NCT00439140
-
CLINICAL_TRIALS study record update · 2013-12-24A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
-
CLINICAL_TRIALS study record update · 2013-11-19Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome
-
CLINICAL_TRIALS study record update · 2013-09-26Effects of Antimuscarinic Drugs on OAB Symptoms After Insertion of Ureteral Stents
-
CLINICAL_TRIALS study record update · 2013-09-26ClinicalTrials.gov study NCT01089751
-
CLINICAL_TRIALS study record update · 2013-09-24Exploratory, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single Center, Web-Based Phase IV Pilot Methodology Trial To Evaluate The Efficacy And Safety Of Tolterodine ER In Subjects With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2013-07-02An Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2013-07-02A Randomized, Double-blind, Parallel Group, Placebo and Active Controlled, Multicenter Dose Ranging Study With the Beta-3 Agonist YM178 in Patients With Symptomatic Overactive Bladder
-
CLINICAL_TRIALS study record update · 2013-05-30Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder (Phase Ⅳ)
-
CLINICAL_TRIALS study record update · 2013-05-16Overactive Bladder Innovative Therapy Trial
-
CLINICAL_TRIALS study record update · 2013-04-30Bladder Thermal Distention for Patients With Refractory Overactive Bladder
-
CLINICAL_TRIALS study record update · 2013-03-05ClinicalTrials.gov study NCT00910520
-
CLINICAL_TRIALS study record update · 2013-03-05ClinicalTrials.gov study NCT00910845
-
CLINICAL_TRIALS study record update · 2013-02-15A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of Solifenacin Succinate as Add-on Therapy for Overactive Bladder (OAB) Symptoms in Men Treated for Benign Prostatic Hyperplasia (BPH) With Tamsulosin Hydrochloride
-
CLINICAL_TRIALS study record update · 2013-01-23Phase II, Randomized, Double-blind, Placebo-controlled Trial of the AOBO-001 for the Treatment of Overactive Bladder With Symptoms of Urge Urinary Incontinence and Frequency
-
CLINICAL_TRIALS study record update · 2013-01-21ClinicalTrials.gov study NCT00932022
-
CLINICAL_TRIALS study record update · 2013-01-17A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine Flexible Dose Regimen In Vulnerable Elderly Patients With Overactive Bladder.
-
CLINICAL_TRIALS study record update · 2013-01-01Physical Therapy for Overactive Bladder
-
CLINICAL_TRIALS study record update · 2012-12-17Pilot Clinical Trial to Study the Effectiveness of a Four-week Exposure to a Transcutaneous, High-frequency, Amplitude-modulated, Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence in Subjects With Idiopathic Overactive Bladder (OAB)